Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19

Viral Infections, Non-HIV

Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial

Lancet.

Furtado RHM, Berwanger O, Fonseca HA, Corrêa TD, Ferraz LR, Lapa MG, Zampieri FG, Veiga VC, Azevedo LCP, Rosa RG, Lopes RD, Avezum A, Manoel ALO, Piza FMT, Martins PA, Lisboa TC, Pereira AJ, Olivato GB, Dantas VCS, Milan EP, Gebara OCE, Amazonas RB, Oliveira MB, Soares RVP, Moia DDF, Piano LPA, Castilho K, Momesso RGRAP, Schettino GPP, Rizzo LV, Neto AS, Machado FR, Cavalcanti AB, COALITION COVID-19 Brazil II Investigators

doi: 10.1016/S0140-6736(20)31862-6.

Viral Infections, Non-HIV

Outcomes among HIV-positive patients hospitalized with COVID-19

J Acquir Immune Defic Syndr.

Karmen-Tuohy S, Carlucci PM, Zervou FN, Zacharioudakis IM, Rebick G, Klein E, Reich J, Jones S, Rahimian J

doi: 10.1097/QAI.0000000000002423.

Viral Infections, Non-HIV

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Clin Infect Dis.

Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O'Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y

doi: 10.1093/cid/ciaa478.

Viral Infections, Non-HIV

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Trials.

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB

doi: 10.1186/s13063-020-04535-4.

Viral Infections, Non-HIV

Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

Crit Rev Oncol Hematol.

Jafari A, Dadkhahfar S, Perseh S

doi: 10.1016/j.critrevonc.2020.102982.

Viral Infections, Non-HIV

The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure

SAGE Open Med Case Rep.

Keith P, Day M, Choe C, Perkins L, Moyer L, Hays E, French M, Hewitt K, Gravel G, Guffey A, Scott LK

doi: 10.1177/2050313X20933473.

Viral Infections, Non-HIV

Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient

Clin Chem Lab Med.

Alvarez JC, Moine P, Etting I, Annane D, Larabi IA

doi: 10.1515/cclm-2020-0612.

Viral Infections, Non-HIV

Convalescent plasma transfusion for the treatment of COVID-19: Systematic review

J Med Virol.

Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A

doi: 10.1002/jmv.25961.

Mechanical Ventilation

Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study

Crit Care

Kooistra EJ, Waalders NJB, Grondman I, Janssen NAF, de Nooijer AH, Netea MG, van de Veerdonk FL, Ewalds E, van der Hoeven JG, Kox M, Pickkers P, RCI-COVID-19 Study Group.

doi: 10.1186/s13054-020-03364-w

Related content

Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial

Outcomes among HIV-positive patients hospitalized with COVID-19

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure

Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient

Convalescent plasma transfusion for the treatment of COVID-19: Systematic review

Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study